Study genes in congenital muscle weakness
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This research study looks at genes and molecules to better understand congenital myopathies (birth-related muscle weakness). It may help explain the cause of symptoms and improve future diagnoses for you and your family.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a clinical diagnosis or a suspected diagnosis of congenital myopathy
- If you’re able, a family member is also willing to take part in the study
- You should not have myotonia congenita or a related condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
This study sets up a patient registry for people diagnosed with myotubular myopathy or centronuclear myopathy. Your information can help researchers better understand these conditions and plan future studies or treatments.
This study looks at how common RYR1-related diseases are by gathering information from people who have a confirmed RYR1 gene change and related symptoms. By joining, you help researchers better understand these rare conditions, which may improve future care.
This study creates a network to gather information about people with nemaline myopathy, a genetic muscle disorder. It aims to improve understanding and support for future research and care.
This study looks at samples from people with muscular dystrophy and from close relatives, to better understand neuromuscular diseases. You may be asked to provide a skin biopsy for research to help with genetic and molecular analysis.
This study looks at how genes affect symptoms in children with congenital myopathies or congenital muscular dystrophies. It may help doctors better understand these conditions.
Hear when a new Central Core Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.